People · Operator
Named in public records as an officer, director or promoter · active 2025–2025 · Other, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Cell Response Formulation, LLC | — | Other | Pre-Seed | $1.0M | $1.7M | — |
| Tropoflex Inc. | — | Biotechnology | Pre-Seed | $250K | $550K | 2025 |
| Tropogenix, Inc. | — | Biotechnology | Pre-Seed | $250K | $535K | 2025 |
Kevin Meehan at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Kevin Meehan on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Paul Castella | 2 | 6 |
| Kristen Parker | 2 | 2 |
| Bryan Daniels | 2 | 2 |
| Diane Peterson | 1 | 1 |
| Robin Farkas | 1 | 1 |
| Dennis Arnold | 1 | 1 |
| Steve Manley | 1 | 1 |
| Gary Trauner | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.